What Happened
Texas Instruments announced acquisition of Silicon Labs for $231/share all-cash (≈$7.5B enterprise value), expected close H1 2027.
The price sequence tells the story:
- Feb 2: $143.42 (pre-rumor close)
- Feb 3: Stock surges ≈39% aftermarket on Bloomberg terminal headline reporting "advanced talks"
- Feb 4: Deal confirmed at $231/share (≈40% premium to pre-rumor) — stock crashes to $136.62
The anomaly: Stock rallied on rumor, then crashed 26% when the deal was actually signed. That's not normal. Markets don't usually sell off on confirmation of a 40% premium deal.
The market is pricing material break risk.
The Numbers
| Metric | Value |
|---|---|
| Deal price | $231.00/share |
| Current price | $136.62 |
| Pre-rumor (Feb 2) | $143.42 |
| Spread to deal | $94.38 (69%) |
| Premium offered | ≈40% (to pre-rumor) |
| Expected close | H1 2027 (12-18 months) |
| TXN reverse termination fee | $499M |
| SLAB termination fee | $259M |
Source: Termination fees from merger agreement per SEC 8-K filing.
What the Spread Implies
A 69% spread on a 12-18 month deal is extraordinary. Normal M&A arb spreads are 1-5% for deals with standard regulatory risk.
Break probability sensitivity analysis:
The implied probability depends heavily on assumed downside if deal breaks:
| If deal breaks, SLAB falls to... | Implied P(break) |
|---|---|
| $143 (pre-rumor level) | ≈93% |
| $130 (modest discount) | ≈85% |
| $120 (material discount) | ≈72% |
| $100 (52-week low area at $83) | ≈55% |
Math: P(close) × $94 upside + P(break) × downside = 0 for market indifference.
The market's bet ranges from 55-93% break probability depending on standalone value assumption. The wide range matters — if you believe SLAB's standalone value is closer to pre-rumor ($143), market is pricing >90% break. If you think a broken deal sends SLAB to $100-110, it's more like 60-70%.
Regulatory Path
What the filing says:
- HSR (Hart-Scott-Rodino) approval explicitly required
- "Other required governmental and regulatory approvals" mentioned generically
- Closing condition: "termination or expiration of any waiting period applicable under the Hart-Scott-Rodino Antitrust Improvements Act"
- Termination rights extend to Feb 2027, with extensions to Aug 2027 and Feb 2028 under certain circumstances relating to regulatory approvals
SAMR (China) — inference, not confirmed: The press release does NOT explicitly mention SAMR or Chinese regulatory approval. However:
- TXN: ≈20% of revenue from China end-customers (per 10-K)
- SLAB: 15% revenue from China end-customers, 32% shipped to China (per 10-K)
- Both companies have manufacturing/assembly operations in Asia
- Precedent: MaxLinear/Silicon Motion required SAMR review; Intel/Tower failed on regulatory
SAMR is likely required but not explicitly stated. The 12-18 month timeline and extended termination rights (to Feb 2028) suggest both parties anticipate complex regulatory path.
Why It Might Fail
1. Semiconductor M&A regulatory precedent is ugly
Recent history:
- MaxLinear/Silicon Motion (2022-2023): 14-month SAMR review, conditional approval, then MaxLinear terminated citing MAE
- DuPont/Rogers (2022): Terminated after prolonged SAMR delays
- GlobalWafers/Siltronic (2022): SAMR approved but German regulatory blocked
- Intel/Tower (2023): Failed to get regulatory signoff
2. The $499M reverse termination fee is telling
TXN agreed to pay SLAB $499M if deal fails due to regulatory issues. That's 7% of deal value — unusually high for a "clean" deal. This is downside protection that suggests both parties see regulatory risk.
3. Trade war backdrop
Deal announced amid ongoing US-China semiconductor tensions. Recent actions include US revoking China waivers, new chip export restrictions, and China's rare earth curbs. SAMR has been slower on US acquirer deals as leverage.
Why It Might Close
1. Both companies are US-based
SLAB is Austin, TX. TXN is Dallas, TX. This is domestic consolidation, not cross-border. China exposure exists via sales and assembly, not ownership. SAMR's jurisdiction is narrower than for deals involving Taiwan (Silicon Motion) or German (Siltronic) targets.
2. Strategic rationale is industrial, not AI/HPC
SLAB is wireless IoT, industrial, medical — not the AI/advanced logic that triggers maximum regulatory scrutiny. TXN is expanding analog/embedded, not acquiring leading-edge technology.
3. TXN is well-capitalized, no financing contingency
Deal funded via cash + debt, no financing condition. TXN has strong balance sheet. This isn't a leveraged PE deal that could collapse on credit.
4. Underlying business is solid
SLAB FY2025: $785M revenue (+34% YoY), non-GAAP operating income $25M, "record opportunity funnel" per CEO. Standalone value provides floor.
What We Don't Know
- Whether SAMR approval is actually required — Filing mentions HSR explicitly but only "other regulatory approvals" generically
- What remedies TXN might offer — AMD/Xilinx closed with behavioral commitments; divestiture possibilities unclear
- Why the aftermarket rally reversed — Feb 3 rumor sent stock up 39%, but Feb 4 confirmation sent it down 26%. Did something emerge between leak and announcement?
- Exact standalone valuation — Pre-rumor was $143, 52-week low was $83. Break probability calculation is highly sensitive to this assumption
The Question
The anomaly here isn't the spread — it's the price action. Stock rallied on leak, crashed on confirmation. Either:
A) Market learned something negative between Feb 3 and Feb 4 — Regulatory concern emerged, terms were worse than expected, or smart money dumped on confirmation
B) Market is irrational — Panic-pricing China risk based on MaxLinear/SIMO PTSD
If (B), this is a mispriced arb with 69% upside over 12-18 months. If (A), the market knows something we don't.
Escalation Rationale
This requires human judgment on:
-
Why did stock crash on deal confirmation? The price action is the puzzle. Normal M&A: stock gaps toward deal price on announcement, not away from it.
-
What's our edge on regulatory probability? SAMR timing is the key variable. Do we have unusual insight?
-
Is standalone value floor solid? Break probability calculation swings wildly (55% to 93%) depending on downside assumption. Need conviction on where SLAB trades if deal breaks.
The spread is too large to ignore. Something is being priced that isn't obvious in the public narrative.
Action items:
- Verify SAMR requirement when TXN files merger agreement 8-K (should include full regulatory condition list)
- Track institutional positioning via 13F filings
- Monitor for any deal amendments or timeline updates
- Set alert for HSR early termination (bullish) or second request (bearish)
// comments (0)